QUAD
Multi-Peptide Recovery Blend (BPC-157 + TB-500 + GHK-Cu + KPV)
KLOW is a proprietary multi-peptide blend formulated for metabolic optimization and body composition research. Combining synergistic peptide compounds at research-relevant doses, KLOW was designed for investigators studying multi-pathway approaches to metabolic function. The 80mg formulation provides a higher peptide payload for sustained research protocols.
Aliases: Multi-peptide blend, Tissue repair blend
- Research score
- 5/10
Key fact
Proprietary 4-peptide repair & anti-inflammatory blend: GHK-Cu 50mg + BPC-157 10mg + TB-500 10mg + KPV 10mg. GLOW's bigger sibling with NF-kB inflammation control.
Mechanism
KLOW is a proprietary multi-peptide blend containing: - Copper tripeptide complex, modulates 4,000+ genes, drives collagen synthesis, tissue remodeling, and copper delivery for antioxidant enzymes - Gastric pentadecapeptide, promotes angiogenesis, NO modulation, growth factor upregulation - Thymosin Beta-4 fragment, actin regulation, systemic cell migration and tissue repair - Alpha-MSH C-terminal tripeptide, potent anti-inflammatory via NF-kB inhibition and PepT1-mediated intestinal uptake The blend targets complementary repair pathways: BPC-157 (local repair signaling), TB-500 (systemic cell migration), GHK-Cu (tissue remodeling and gene expression), and KPV (inflammation control).
Evidence note
Experimental — No research on the blend itself. Individual components range from Experimental (BPC-157, TB-500, KPV) to Emerging (GHK-Cu). The synergistic rationale is sound but unvalidated as a combination.
Studies
Emerging Use of BPC-157 in Orthopaedic Sports Medicine: Systematic Review
Significant preclinical evidence for musculoskeletal healing via angiogenesis and anti-inflammatory properties. Tissue repair component of KLOW blend.
Open sourcePepT1-Mediated Tripeptide KPV Uptake Reduces Intestinal Inflammation
Orally delivered KPV decreases colitis severity via NF-kB inhibition. Anti-inflammatory foundation for KLOW's inflammation management component.
Open sourceUtilizing Thymosin Beta-4 to Remind Adult Organs of Their Embryonic State
Thymosin Beta-4 activates embryonic repair programs in adult tissue; promotes cardiac and tissue regeneration. Systemic repair component of KLOW blend.
Open source
FAQ
How do I dose a multi-peptide blend like KLOW?
Reconstitute with 2mL bacteriostatic water (40mg/mL). Standard dose is 0.1-0.2mL daily (4-8mg total blend), providing ~250-500mcg each of BPC-157, TB-500, and KPV, plus 1.25-2.5mg GHK-Cu per injection. Cycle for 4-8 weeks.
What is the difference between KLOW and GLOW?
KLOW is GLOW + KPV. GLOW (70mg) contains GHK-Cu, TB-500, and BPC-157 for skin and tissue repair. KLOW (80mg) adds KPV (10mg) for targeted anti-inflammatory support via NF-kB inhibition. If inflammation management is important to your research, KLOW is the upgrade.
What peptides are in the KLOW blend?
KLOW contains GHK-Cu (50mg) for tissue remodeling and gene expression modulation, BPC-157 (10mg) for local repair signaling, TB-500 (10mg) for systemic cell migration and repair, and KPV (10mg) for NF-kB-mediated anti-inflammatory control. Total: 80mg.
For research and educational use only. This content is not medical advice.